List of Kura Oncology, Inc. patents

List of Kura Oncology, Inc. patents

List of Nortek Global HVAC patents

List of NOVELDA patents

List of Omega Flex, Inc. patents

CEOs of augmented reality companies

List of awards received by Michael Ballack

Patents where

Current Assignee

Name

is

Kura Oncology, Inc.

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 11291663 Methods of treating cancer with farnesyltransferase inhibitors	Patent 11291663 was granted and assigned to Kura Oncology, Inc. on April, 2022 by the United States Patent and Trademark Office.	Kura Oncology, Inc.	Kura Oncology, Inc.		United States Patent and Trademark Office	11291663	April 5, 2022
	‌ US Patent 11649251 Substituted inhibitors of menin-MLL and methods of use	Patent 11649251 was granted and assigned to Kura Oncology, Inc. on May, 2023 by the United States Patent and Trademark Office.	Kura Oncology, Inc.	Kura Oncology, Inc.		United States Patent and Trademark Office	11649251	May 16, 2023
	‌ US Patent 9951078 Inhibitors of ERK and methods of use	Patent 9951078 was granted and assigned to Kura Oncology, Inc. on April, 2018 by the United States Patent and Trademark Office.	Kura Oncology, Inc.	Kura Oncology, Inc.		United States Patent and Trademark Office	9951078	April 24, 2018
	‌ US Patent 11541045 Methods of treating cancer with farnesyltransferase inhibitors		Kura Oncology, Inc.	Kura Oncology, Inc.		United States Patent and Trademark Office	11541045	January 3, 2023
	‌ US Patent 11542244 Synthesis of tipifarnib	Patent 11542244 was granted and assigned to Kura Oncology, Inc. on January, 2023 by the United States Patent and Trademark Office.	Kura Oncology, Inc.	Kura Oncology, Inc.		United States Patent and Trademark Office	11542244	January 3, 2023
	‌ US Patent 10980793 Methods of treating cancer with farnesyltransferase inhibitors	Patent 10980793 was granted and assigned to Kura Oncology, Inc. on April, 2021 by the United States Patent and Trademark Office.	Kura Oncology, Inc.	Kura Oncology, Inc.		United States Patent and Trademark Office	10980793	April 20, 2021
	‌ US Patent 10292979 Methods of treating cancer patients with farnesyltransferase inhibitors	Patent 10292979 was granted and assigned to Kura Oncology, Inc. on May, 2019 by the United States Patent and Trademark Office.	Kura Oncology, Inc.	Kura Oncology, Inc.		United States Patent and Trademark Office	10292979	May 21, 2019
	‌ US Patent 10335404 Methods of treating cancer patients with farnesyltransferase inhibitors	Patent 10335404 was granted and assigned to Kura Oncology, Inc. on July, 2019 by the United States Patent and Trademark Office.	Kura Oncology, Inc.	Kura Oncology, Inc.		United States Patent and Trademark Office	10335404	July 2, 2019
	‌ US Patent 11207314 Methods of treating cancer patients with farnesyltransferase inhibitors	Patent 11207314 was granted and assigned to Kura Oncology, Inc. on December, 2021 by the United States Patent and Trademark Office.	Kura Oncology, Inc.	Kura Oncology, Inc.		United States Patent and Trademark Office	11207314	December 28, 2021
	‌ US Patent 10806730 Methods of treating cancer with farnesyltransferase inhibitors	Patent 10806730 was granted and assigned to Kura Oncology, Inc. on October, 2020 by the United States Patent and Trademark Office.	Kura Oncology, Inc.	Kura Oncology, Inc.		United States Patent and Trademark Office	10806730	October 20, 2020
	‌ US Patent 10137121 Methods of treating cancer with farnesyltransferase inhibitors	Patent 10137121 was granted and assigned to Kura Oncology, Inc. on November, 2018 by the United States Patent and Trademark Office.	Kura Oncology, Inc.	Kura Oncology, Inc.		United States Patent and Trademark Office	10137121	November 27, 2018
	‌ US Patent 9956215 Methods of treating cancer with farnesyltransferase inhibitors	Patent 9956215 was granted and assigned to Kura Oncology, Inc. on May, 2018 by the United States Patent and Trademark Office.	Kura Oncology, Inc.	Kura Oncology, Inc.		United States Patent and Trademark Office	9956215	May 1, 2018
	‌ US Patent 10301317 Inhibitors of ERK and methods of use	Patent 10301317 was granted and assigned to Kura Oncology, Inc. on May, 2019 by the United States Patent and Trademark Office.	Kura Oncology, Inc.	Kura Oncology, Inc.		United States Patent and Trademark Office	10301317	May 28, 2019
	‌ US Patent 11124839 Methods of treating cancer patients with farnesyltransferase inhibitors	Patent 11124839 was granted and assigned to Kura Oncology, Inc. on September, 2021 by the United States Patent and Trademark Office.	Kura Oncology, Inc.	Kura Oncology, Inc.		United States Patent and Trademark Office	11124839	September 21, 2021
	‌ US Patent 12018011 Macrocyclic compounds and compositions, and methods of preparing and using the same	Patent 12018011 was granted and assigned to Kura Oncology, Inc. on June, 2024 by the United States Patent and Trademark Office.	Kura Oncology, Inc.	Kura Oncology, Inc.		United States Patent and Trademark Office	12018011	June 25, 2024
	‌ US Patent 11944627 Methods for treating hematological malignancies and Ewing's sarcoma	Patent 11944627 was granted and assigned to Kura Oncology, Inc. on April, 2024 by the United States Patent and Trademark Office.	Kura Oncology, Inc.	Kura Oncology, Inc.		United States Patent and Trademark Office	11944627	April 2, 2024
	‌ US Patent 11672774 Methods of treating squamous cell carcinomas with farnesyltransferase inhibitors		Kura Oncology, Inc.	Kura Oncology, Inc.		United States Patent and Trademark Office	11672774	June 13, 2023

17 results

0 selected

17 results

0 selected